Thus, deletion of Jag1 was associated with significantly increased incidence of cystic neoplasms and decreased incidence of PDAC (χ2 test, P < 0.0001), suggesting a switch from ductal adenocarcinoma to cystic neoplasms. Here, JAG1 is linked to invasive ductal breast carcinoma.